Nyxoah SA
NASDAQ:NYXH 10:52:45 AM EDT
Market Cap (Intraday) | 273.72M |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $10.19 |
50-Day MA | $13.57 |
200-Day MA | $8.39 |
Nyxoah SA Stock, NASDAQ:NYXH
Rue Edouard Belin 12, Mont-Saint-Guibert, Walloon Region 1435
Belgium
Phone: +32.10.22.23.55
Number of Employees: 146.8
Description
Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). Its solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe OSA. The company was founded by Robert Taub and Adi Mashiach on July 15, 2009, and is headquartered in Mont-Saint-Guibert, Belgium.